These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6399370)

  • 1. [Comparative pharmacodynamic studies of insulin Maxirapid Polfa and Actrapid MC Novo using Biostator GCIIS].
    Sieradzki J
    Pol Tyg Lek; 1984 Apr; 39(18):615-7. PubMed ID: 6399370
    [No Abstract]   [Full Text] [Related]  

  • 2. Improvement of artificial endocrine pancreas (Biostator; GCIIS) performance combining feedback controlled insulin administration with a pre-programmed insulin infusion.
    Calabrese G; Bueti A; Zega G; Giombolini A; Bellomo G; Antonella MA; Massi-Benedetti M; Brunetti P
    Horm Metab Res; 1982 Oct; 14(10):505-7. PubMed ID: 6757081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A comparative study of intensive conventional insulin treatment and a multiple insulin-injection regimen with NovoPen].
    Ditzel J; Clemmensen NK
    Ugeskr Laeger; 1987 May; 149(20):1335-8. PubMed ID: 3299948
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of purified insulins on insulin requirement and metabolic control.
    Yajnik VH; Vatsraj DJ; Vora LS; Patel SI; Kapur A
    J Assoc Physicians India; 1990 Apr; 38(4):281-2. PubMed ID: 2202711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term improvement in metabolic control of unstable type I diabetes by s.c. insulin injection patterns based on the dose profiles required by bed-side artificial beta-cell.
    Bombor H; Bruns W; Ratzmann KP; Jutzi E; Albrecht G; Michaelis D; Fischer U
    Exp Clin Endocrinol; 1984 Apr; 83(2):143-51. PubMed ID: 6373316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian rhythm of growth hormone, free and total insulin during the treatment with artificial B-cell (Biostator GCIIS).
    Sieradzki J; Szybiński Z; Izworski A; Gołda W
    Endokrynol Pol; 1983; 34(2):73-80. PubMed ID: 6354700
    [No Abstract]   [Full Text] [Related]  

  • 7. [Insulin needs of insulin-dependent diabetics during biostator control and subcutaneous use of insulin].
    Petkova M; Khristov V; Tsanev A
    Vutr Boles; 1990; 29(1):74-7. PubMed ID: 2204207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of the effectiveness of conventional and intensive insulin therapy in the treatment of diabetes mellitus type 1 in pregnant women or those planning pregnancy].
    Podgórski G; Tatoń J; Czech A; Laz R; Szałkiewicz G
    Pol Tyg Lek; 1987 Dec; 42(50):1571-6. PubMed ID: 3330793
    [No Abstract]   [Full Text] [Related]  

  • 9. [Analysis of the daily insulin requirements as determined by a biostator (artificial pancreas) in patients with insulin-dependent diabetes mellitus].
    Djurić DS; Mićić JV; Micić D; Brkić V; Nesović M; Djordjević P; Dragasević M
    Srp Arh Celok Lek; 1983; 111(9-10):1351-60. PubMed ID: 6399414
    [No Abstract]   [Full Text] [Related]  

  • 10. [Counterregulatory hormonal response in short-term induced hypoglycemia in insulin-dependent diabetics].
    Micić D; Popović V; Nesović M; Banović D; Subotić Z
    Srp Arh Celok Lek; 1987 Feb; 115(2):153-67. PubMed ID: 3313753
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of twice daily regimens of Actrapid and Monotard insulins.
    Akintewe TA
    East Afr Med J; 1985 Mar; 62(3):196-9. PubMed ID: 3893969
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison between monocomponent human insulin U-40 and U-100 in CSII treatment of type 1 diabetics.
    Capani F; Carta Q; Vannini P; Ciaverella A; Consoli A; Fiocchi F; Monge L; Vitacolonna E; Sensi S
    Diabetes Res; 1986 Jul; 3(6):317-20. PubMed ID: 3530595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a glucose-controlled insulin infusion system in children and adolescents with insulin-dependent diabetes.
    Golden MP; Myers GL; Tanner SM; Marrero DG; Charles MA
    Pediatrics; 1982 Jul; 70(1):36-42. PubMed ID: 7088631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of the biostator (artificial pancreas) in the treatment of patients with diabetes mellitus].
    Spesivtseva VG; Mamaeva GG; Belokrinitskiĭ DV; Starosel'tseva LK; Turova EA
    Klin Med (Mosk); 1984 Oct; 62(10):55-60. PubMed ID: 6513454
    [No Abstract]   [Full Text] [Related]  

  • 15. Possible differences in potency of purified pork insulins: confirmation by the euglycemic clamp technique.
    Mangan MM; Kemp FW; Akgun S; Ertel NH
    Diabetes Res; 1987 Apr; 4(4):201-5. PubMed ID: 3304784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulinkinetic and -dynamic in diabetic patients under insulin pump therapy after injections of human insulin or the insulin analogue (B28Asp).
    Wiefels K; Hübinger A; Dannehl K; Gries FA
    Horm Metab Res; 1995 Sep; 27(9):421-4. PubMed ID: 8557242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intensified insulin therapy in children and adolescents with labile diabetes mellitus].
    Lebedev NB; Shcherbacheva LN; Kniazeva AP; Lobanova AM
    Pediatriia; 1989; (11):75-9. PubMed ID: 2691980
    [No Abstract]   [Full Text] [Related]  

  • 18. The absorption of subcutaneously injected short-acting soluble insulin: influence of injection technique and concentration.
    Hildebrandt P; Sestoft L; Nielsen SL
    Diabetes Care; 1983; 6(5):459-62. PubMed ID: 6400706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combined use of automatic systems for treating patients with type 1 diabetes mellitus].
    Perelygina AA; Antsiferov MB; Starostina EG
    Probl Endokrinol (Mosk); 1987; 33(5):3-6. PubMed ID: 3422932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The basic bolus principle of insulin therapy. Renaissance of an old treatment concept].
    Rosak C; Böhm BO; Althoff PH; Schöffling K
    Med Klin (Munich); 1986 May; 81(10):341-5. PubMed ID: 3537659
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.